UK bioceramic maker targets device market:
This article was originally published in Clinica
Biocomposites has separated from its parent company in a £1.4 million management buyout, assisted by venture capital funding from 3i. Biocomposites was founded as a subsidiary of Jesse Shirley, a porcelain material manufacturer, in 1993 to fulfill demand for high purity ceramic products. The company aims to target demand for resorbable materials in the device market.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.